Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Marta Seghieri"'
Autor:
Ele Ferrannini, Ricardo Pereira-Moreira, Marta Seghieri, Eleni Rebelos, Aglécio L Souza, Valeria B Chueire, Caterina Arvia, Elza Muscelli
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Introduction Insulin regulates renal glucose production and utilization; both these fluxes are increased in type 2 diabetes (T2D). Whether insulin also controls urinary glucose excretion is not known.Methods We applied the pancreatic clamp technique
Externí odkaz:
https://doaj.org/article/51834c734e6a4280a6d2b47fb9b11d78
Autor:
Anna Solini, Livia Giannini, Marta Seghieri, Edoardo Vitolo, Stefano Taddei, Lorenzo Ghiadoni, Rosa Maria Bruno
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background Sodium-glucose cotransporter-2 inhibitors reduce blood pressure (BP) and renal and cardiovascular events in patients with type 2 diabetes through not fully elucidated mechanisms. Aim of this study was to investigate whether dapagl
Externí odkaz:
https://doaj.org/article/a8c16a4bc32749c98262f53adcbd7812
Autor:
Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Tina Vilsbøll
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrome, increases worldwide representing now the prevalent liver disease in western countries. No
Externí odkaz:
https://doaj.org/article/697d3dde56774883886c2084c52f1264
Autor:
Rosa Maria Bruno, Livia Giannini, Marta Seghieri, Edoardo Vitolo, Stefano Taddei, Lorenzo Ghiadoni, Anna Solini
Publikováno v:
Artery Research, Vol 20 (2017)
Objective: Sodium-glucose co-transporter-2 inhibitors reduce blood pressure and renal and cardiovascular events in patients with type 2 diabetes through not fully elucidated mechanisms. Aim of this study was to investigate whether dapagliflozin is ab
Externí odkaz:
https://doaj.org/article/b8f1a3bb01cd4c8d9c790e0eb4fcb8e2
Autor:
Anna Fedi, Franco Cipollini, Enrica Arcangeli, Gianna Fabbri, Laura Policardo, Marta Seghieri, Giuseppe Seghieri
Publikováno v:
Italian Journal of Medicine, Vol 9, Iss 3, Pp 273-278 (2015)
Low birth-weight (BW) is related to rise in blood pressure (BP) later in life. Aim of this study is investigating whether presence of overweight-obesity modifies this relationship, independently from any additional correlate of metabolic syndrome. We
Externí odkaz:
https://doaj.org/article/da39730c1dde47ae923f3790e3f19780
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 9, p 235 (2018)
The ß-cell dysfunction of type 2 diabetes is partly reversible. The optimal time window to induce glycemic remission is uncertain; short courses of insulin treatment have been tested as a strategy to induce remission. In a pilot study in 38 newly-di
Externí odkaz:
https://doaj.org/article/642ad42a26a14673b322eb054226aaa2
Autor:
Costanza Gaudio, Marta Seghieri, Chiara Merciai, Claudia Colombi, Giuseppe Spatoliatore, Cristiana Maria Baggiore, Alberto Rosati
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 131:254-259
Background Approximately one-fourth of patients treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i) experience an acute estimated glomerular filtration rate (eGFR) reduction of more than 10% (“dippers”). High sodium and protein intake
Autor:
Domenico Tricò, Alessandro Mengozzi, Simona Baldi, Roberto Bizzotto, Oladapo Olaniru, Klaudia Toczyska, Guo Cai Huang, Marta Seghieri, Silvia Frascerra, Stephanie A. Amiel, Shanta Persaud, Peter Jones, Andrea Mari, Andrea Natali
Publikováno v:
Tricò, D, Mengozzi, A, Baldi, S, Bizzotto, R, Olaniru, O, Toczyska, K, Huang, G C, Seghieri, M, Frascerra, S, Amiel, S A, Persaud, S, Jones, P, Mari, A & Natali, A 2022, ' Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals ', Metabolism, vol. 134, no. 155247, 155247 . https://doi.org/10.1016/j.metabol.2022.155247
Aims: Hypertriglyceridemia is associated with an increased risk of type 2 diabetes. We aimed to comprehensively examine the effects of hypertriglyceridemia on major glucose homeostatic mechanisms involved in diabetes progression.Methods: In this rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a517a23ff4634a87b99e3cc1f197dc
https://kclpure.kcl.ac.uk/en/publications/1e5367f8-9c75-46b9-adc5-ba20257ff0bc
https://kclpure.kcl.ac.uk/en/publications/1e5367f8-9c75-46b9-adc5-ba20257ff0bc
Autor:
Costanza Gaudio, Claudia Colombi, Chiara Merciai, Marta Seghieri, Giuseppe Spatoliatore, Alberto Rosati
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS SGLT2 inhibitors (SGLT2i) are able to decrease proteinuria and slow down eGFR decline in DKD patients. The effect is mainly obtained by increase of natriuresis and glucose-induced osmotic diuresis, resulting in a reduction in intr
Autor:
Marta Seghieri, Brenno Astiarraga, Andrea Mari, Andrea Natali, Alessandro Mengozzi, Domenico Tricò, Simona Baldi
Publikováno v:
Diabetes. 70
Chronic hypertriglyceridemia is associated with reduced glucose tolerance. Whether this association is mediated by triglycerides or free fatty acids (FFA) and which mechanisms are involved is unclear. To examine the effect of excess triglycerides alo